Med-Chemist : "Quintessential Medicinal Chemistry"
Monday, January 20, 2020
FDA Approves EluRyng (etonogestrel/ethinyl estradiol vaginal ring), the First Generic NuvaRing
›
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced that it has received Abbreviated New Drug Applicatio...
Friday, January 17, 2020
FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease
›
Kyowa Kirin Co., Ltd., (Kyowa Kirin, TYO: 4151) announced the U.S. Food and Drug Administration (FDA) has granted approval for Nouri...
Thursday, January 16, 2020
FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older
›
In continuation of my update on amlodipine Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quali...
Wednesday, January 15, 2020
Turalio (Pexidartinib) Approved to Treat Tenosynovial Giant Cell Tumor
›
In continuation of my update on pexidartinib Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic te...
Tuesday, January 14, 2020
FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease
›
In continuation of my update on Gadavist (gadobutrol) Bayer announced today the U.S. Food and Drug Administration (FDA) has approved...
Monday, January 13, 2020
FDA Approves Nouress (cysteine hydrochloride) Injection for Treating Neonate Patients Requiring Total Parenteral Nutrition (TPN)
›
Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced today that the U.S. Food and Drug Administration (FDA) has approved Nouress (A...
Saturday, January 11, 2020
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
›
In continuation of my update on Otezla (apremilast) Celgene Corporation today announced that the U.S. Food and Drug Administration...
Friday, January 10, 2020
FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults
›
Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency, announces tha...
Thursday, January 9, 2020
FDA Approves Nubeqa (darolutamide) for Men with Non-Metastatic Castration-Resistant Prostate Cancer
›
The U.S. Food and Drug Administration (FDA) today approved Nubeqa (darolutamide), an androgen receptor inhibitor (ARi), for the tr...
Wednesday, January 8, 2020
FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma
›
In continuation of my update on (fluticasone propionate and salmeterol Teva Pharmaceutical Industries Ltd. (NYSE and TASE...
Tuesday, January 7, 2020
Selinexor Offers Hope Against a Tough-to-Treat Blood Cancer
›
In continuation of my update on Selinexor Patients with a form of blood cancer known as multiple myeloma who haven't responde...
FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults
›
U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptom...
Sunday, January 5, 2020
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
›
In continuation of my update on Selinexor Karyopharm Therapeutics Inc. an oncology-focused pharmaceutical company, announced that ...
Saturday, January 4, 2020
FDA Approves Thiola EC (tiopronin) for the Treatment of Cystinuria
›
Retrophin, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of Thiola EC (tiopronin)...
‹
›
Home
View web version